Literature DB >> 3198569

Use of buspirone in an adolescent with overanxious disorder.

H R Kranzler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3198569     DOI： 10.1097/00004583-198811000-00022

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN： 0890-8567            Impact factor:   8.829


× No keyword cloud information.
  4 in total

Review 1.  Buspirone in Children and Adolescents with Anxiety: A Review and Bayesian Analysis of Abandoned Randomized Controlled Trials.

Authors:  Jeffrey R Strawn; Jeffrey A Mills; Gary J Cornwall; Sarah A Mossman; Sara T Varney; Brooks R Keeshin; Paul E Croarkin
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-08-28       Impact factor: 2.576

Review 2.  Separation anxiety disorder in children and adolescents: epidemiology, diagnosis and management.

Authors:  G Masi; M Mucci; S Millepiedi
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 3.  Pharmacological treatment of psychiatric disorders in children and adolescents: focus on guidelines for the primary care practitioner.

Authors:  N J Carrey; D M Wiggins; R P Milin
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

Review 4.  A risk-benefit assessment of pharmacotherapy for anxiety disorders in children and adolescents.

Authors:  S M Hawkridge; D J Stein
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.